Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Mar 21;3(3):161-6.
doi: 10.1021/cn200093r. Epub 2011 Dec 19.

Detection of asymptomatic nigrostriatal dopaminergic lesion in rats by exhaled air analysis using carbon nanotube sensors

Affiliations

Detection of asymptomatic nigrostriatal dopaminergic lesion in rats by exhaled air analysis using carbon nanotube sensors

Ulrike Tisch et al. ACS Chem Neurosci. .

Abstract

The ante-mortem diagnosis of Parkinson's disease (PD) still relies on clinical symptoms. Biomarkers could in principle be used for the early detection of PD-related neuronal damage, but no validated, inexpensive, and simple biomarkers are available yet. Here we report on the breath-print of presymptomatic PD in rats, using a model with 50% lesion of dopaminergic neurons in substantia nigra. Exhaled breath was collected from 19 rats (10 lesioned and 9 sham operated) and analyzed using organically functionalized carbon nanotube sensors. Discriminant factor analysis detected statistically significant differences between the study groups and a classification accuracy of 90% was achieved using leave-one-out cross-validation. The sensors' breath-print was supported by determining statistically significant differences of several volatile organic compounds in the breath of the lesioned rats and the sham operated rats, using gas chromatography combined with mass spectrometry. The observed breath-print shows potential for cost-effective, fast, and reliable early PD detection.

Keywords: Parkinsonism; breath analysis; early diagnosis; nanomaterial; sensor; volatile organic compound.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Amount of dopamine in striatal tissue. Rats treated with the toxin 6-hydroxydopamine (6OHDA 250 μg, by intracerebroventricular injection) showed a 55 ± 5% lower level of dopamine in the striatal tissue homogenate compared to control animals (standard error of the mean, SEM, for 9–10 rats per treatment, ***p < 0.001).
Figure 2
Figure 2
DFA plot of the first canonical variable that was calculated from the responses of two RN-CNT sensors to the 6-OHDA treated rats and the sham operated control animals. Each rat is represented by 1 point in the plot. The standard distribution (SD) of the CV1 values is represented by the error bars. The boxes represent the 95% confidence intervals of the CV1 values, corresponding to 1.96 × SEM.
Figure 3
Figure 3
Abundance of volatile organic compounds (VOCs) that were found in the breath of >80% of both the 6-OHDA treated and sham operated rats. The columns represent the average abundance and the error bars mark the borders of the 90% CIs. The VOCs were tentatively identified.

Similar articles

Cited by

References

    1. Wright W. A.; Evanoff B. A.; Lian M.; Criswell S. R.; Racette B. A. (2010) Geographic and ethnic variation in Parkinson disease: A population-based study of US medicare beneficiaries. Neuroepidemiology 34, 143–151. - PMC - PubMed
    1. de Rijk M. C.; Launer L. J.; Berger K.; Breteler M. M.; Dartigues J. F.; Baldereschi M.; Fratiglioni L.; Lobo A.; Martinez-Lage J.; Trenkwalder C.; Hofman A. (2000) Prevalence of Parkinson’s disease in Europe: A collaborative study of population-based cohorts. Neurology 54, S21–S23. - PubMed
    1. Lozano A. M.; Kalia S. K. (2005) New movement in Parkinson’s. Sci. Am. 293, 68–75. - PubMed
    1. Braak H.; Del Tredici K.; Rub U.; de Vos R. A.; Jansen Steur E. N.; Braak E. (2003) Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol. Aging 24, 197–211. - PubMed
    1. Schrag A.; Ben-Shlomo Y.; Quinn N. (2002) How valid is the clinical diagnosis of Parkinson’s disease in the community?. J. Neurol. Neurosurg. Psychiatry 73, 529–534. - PMC - PubMed